BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10037100)

  • 21. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
    Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
    J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genital tract HIV RNA levels and their associations with human papillomavirus infection and risk of cervical precancer.
    Ghartey J; Kovacs A; Burk RD; Stewart Massad L; Minkoff H; Xie X; Dʼsouza G; Xue X; Heather Watts D; Levine AM; Einstein MH; Colie C; Anastos K; Eltoum IE; Herold BC; Palefsky JM; Strickler HD
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):316-23. PubMed ID: 24694931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
    Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
    Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse.
    Piketty C; Darragh TM; Da Costa M; Bruneval P; Heard I; Kazatchkine MD; Palefsky JM
    Ann Intern Med; 2003 Mar; 138(6):453-9. PubMed ID: 12639077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intraepithelial cervical carcinoma and HIV. Prevalence, risk factors and prevention strategies].
    Soncini E; Condemi V
    Minerva Ginecol; 2003 Feb; 55(1):51-5. PubMed ID: 12598843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
    Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
    AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.
    Massad LS; Ahdieh L; Benning L; Minkoff H; Greenblatt RM; Watts H; Miotti P; Anastos K; Moxley M; Muderspach LI; Melnick S
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):432-42. PubMed ID: 11511819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
    J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions.
    Clavel C; Masure M; Levert M; Putaud I; Mangeonjean C; Lorenzato M; Nazeyrollas P; Gabriel R; Quereux C; Birembaut P
    Diagn Mol Pathol; 2000 Sep; 9(3):145-50. PubMed ID: 10976721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany.
    Remschmidt C; Kaufmann AM; Hagemann I; Vartazarova E; Wichmann O; Deleré Y
    Int J Gynecol Cancer; 2013 Mar; 23(3):519-26. PubMed ID: 23360813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.
    Goldie SJ; Freedberg KA; Weinstein MC; Wright TC; Kuntz KM
    Am J Med; 2001 Aug; 111(2):140-9. PubMed ID: 11498068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus infection in women infected with the human immunodeficiency virus.
    Sun XW; Kuhn L; Ellerbrock TV; Chiasson MA; Bush TJ; Wright TC
    N Engl J Med; 1997 Nov; 337(19):1343-9. PubMed ID: 9358128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women.
    Levi JE; Fernandes S; Tateno AF; Motta E; Lima LP; Eluf-Neto J; Pannuti CS
    Gynecol Oncol; 2004 Jan; 92(1):225-31. PubMed ID: 14751163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Squamous intraepithelial cervical lesions in human immunodeficiency virus-seropositive women.
    Sopracordevole F; Campagnutta E; Parin A; Vaccher E; Volpe R; Scarabelli C
    J Reprod Med; 1996 Aug; 41(8):586-90. PubMed ID: 8866386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term follow up of cervical squamous intraepithelial lesions associated with HIV and human papillomavirus infections in Africa.
    La Ruche G; Leroy V; Mensah-Ado I; Ramon R; You B; Bergeron C; Mothebesoane-Anoh S; Touré-Coulibaly K; Dabis F
    Int J STD AIDS; 1999 Jun; 10(6):363-8. PubMed ID: 10414878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.
    Minkoff H; Ahdieh L; Massad LS; Anastos K; Watts DH; Melnick S; Muderspach L; Burk R; Palefsky J
    AIDS; 2001 Nov; 15(16):2157-64. PubMed ID: 11684935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Human papillomavirus genotype distribution in cervical infections among woman in La Plata, Argentina].
    Abba MC; Gomez MA; Golijow CD
    Rev Argent Microbiol; 2003; 35(2):74-9. PubMed ID: 12920987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
    Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
    Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.